The New England journal of medicine
-
Randomized Controlled Trial Multicenter Study Clinical Trial
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
Restenosis after coronary stenting necessitates repeated percutaneous or surgical revascularization procedures. The delivery of paclitaxel to the site of vascular injury may reduce the incidence of neointimal hyperplasia and restenosis. ⋯ As compared with bare-metal stents, the slow-release, polymer-based, paclitaxel-eluting stent is safe and markedly reduces the rates of clinical and angiographic restenosis at nine months.
-
Randomized Controlled Trial Clinical Trial
A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis.
Neurocysticercosis is the main cause of adult-onset seizures in the developing world. Whether therapy with antiparasitic agents results in improved seizure control has been questioned because of the lack of adequate, controlled studies. ⋯ In patients with seizures due to viable parenchymal cysts, antiparasitic therapy decreases the burden of parasites and is safe and effective, at least in reducing the number of seizures with generalization.